KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Organon (OGN) EPS (Weighted Average and Diluted) (2020 - 2026)

Organon has reported EPS (Weighted Average and Diluted) over the past 7 years, most recently at $0.55 for Q1 2026.

  • For Q1 2026, EPS (Weighted Average and Diluted) rose 66.67% year-over-year to $0.55; the TTM value through Mar 2026 reached $0.94, down 67.25%, while the annual FY2025 figure was $0.72, 78.38% down from the prior year.
  • EPS (Weighted Average and Diluted) for Q1 2026 was $0.55 at Organon, up from -$0.78 in the prior quarter.
  • Over five years, EPS (Weighted Average and Diluted) peaked at $2.13 in Q4 2023 and troughed at -$0.78 in Q4 2025.
  • A 5-year average of $0.72 and a median of $0.69 in 2023 define the central range for EPS (Weighted Average and Diluted).
  • Biggest five-year swings in EPS (Weighted Average and Diluted): skyrocketed 500.0% in 2024 and later tumbled 290.24% in 2025.
  • Year by year, EPS (Weighted Average and Diluted) stood at $0.42 in 2022, then skyrocketed by 407.14% to $2.13 in 2023, then crashed by 80.75% to $0.41 in 2024, then tumbled by 290.24% to -$0.78 in 2025, then surged by 170.51% to $0.55 in 2026.
  • Business Quant data shows EPS (Weighted Average and Diluted) for OGN at $0.55 in Q1 2026, -$0.78 in Q4 2025, and $0.61 in Q3 2025.